-
Course Overview Note
|
2013
(Revised from original 2013 version)
The Entrepreneurial Manager: Course Overview, 2013 Winter Term
Richard G. Hamermesh, Richard G. Hamermesh and Thomas Eisenmann
Course overview of The Entrepreneurial Manager.
Keywords: Entrepreneurship;
Management;
Business Education;
-
Supplement
| HBS Case Collection
|
2012
Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Instructors (Brief Case)
Richard G. Hamermesh and Alisa Zalosh
-
Supplement
| HBS Case Collection
|
2012
Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Students (Brief Case)
Richard G. Hamermesh and Alisa Zalosh
-
Teaching Note
| HBS Case Collection
|
2012
Westlake Lanes: How Can This Business Be Saved? (Brief Case)
Richard G. Hamermesh and Alisa Zalosh
-
Supplement
| HBS Case Collection
|
2012
Sugar Bowl, Spreadsheet for Instructors (Brief Case) (CW)
Richard G. Hamermesh and Alisa Zalosh
-
Supplement
| HBS Case Collection
|
2012
Sugar Bowl, Spreadsheet for Students (Brief Case) (CW)
Richard G. Hamermesh and Alisa Zalosh
-
Teaching Note
| HBS Case Collection
|
2012
Sugar Bowl (Brief Case) (TN)
Richard G. Hamermesh and Alisa Zalosh
-
Case
| HBS Case Collection
|
2012
Sugar Bowl
Richard G. Hamermesh and Alisa Zalosh
Shelby Givens, a recent business school graduate, returned home to Raleigh, North Carolina, to help rescue her family's ailing and outdated bowling alley, Westlake Lanes. Although she cut costs and addressed inefficiencies, moving the business from near-bankruptcy to profitability in nine months, market conditions threatened the long-term viability of the business. Givens then sold her family on a new, more youth-oriented concept, an urban lounge called Sugar Bowl that could generate sizable revenues from the food and beverage businesses already embedded in Westlake Lanes. The case follows Givens as she builds Sugar Bowl into a turnaround story through shrewd decision making in finance, operations, and marketing, while contending constantly with challenging surprises and disappointments. The case also captures Givens's reflections on how the entrepreneurial drive has motivated her. Sugar Bowl may be taught alone or after "Westlake Lanes" (4431), which follows Givens through the initial turnaround process.
Keywords: Family Business;
Entrepreneurship;
Operations;
Performance;
Business Strategy;
Corporate Finance;
Entertainment and Recreation Industry;
Raleigh;
Citation:
Hamermesh, Richard G., and Alisa Zalosh. "
Sugar Bowl." Harvard Business School Brief Case 913-537, November 2012.
-
Teaching Note
| HBS Case Collection
|
2012
Gene Patents (A) (TN)
Richard G. Hamermesh and Matthew Preble
This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues deal with potential implications of Judge Sweet's decision for biotechnology entrepreneurs and investors.
Keywords: patents;
genetics;
biotech;
Human Genome;
Patents;
Genetics;
Biotechnology Industry;
United States;
Citation:
Hamermesh, Richard G., and Matthew Preble. "
Gene Patents (A) (TN)." Harvard Business School Teaching Note 813-099, December 2012.
-
Case
| HBS Case Collection
|
2013
(Revised from original 2012 version)
Companion Diagnostics: Uncertainties for Approval and Reimbursement
Richard G. Hamermesh, Norman C. Selby and Phillip Andrews
The FDA approvals of novel therapeutics were seen as signs in the personalized medicine community of real progress in the growth of personalized medicine. The FDA's approval of such drugs, along with companion diagnostics, suggested a shift in thinking and regulatory practices at the agency. Beyond the regulatory questions, many considered the reimbursement system archaic, dispersed, unpredictable, and unnecessarily time consuming. Many questioned whether the traditional models of reimbursement were relevant in the era of personalized medicine, and who should be covering the cost of tests needed to identify the sometimes small number of patients who could benefit from expensive targeted drugs. This case focuses on the array of possibilities and the ambiguity surrounding these regulatory and reimbursement issues.
Keywords: models of reimbursement;
personalized medicine;
regulation;
healthcare reform;
Health Care and Treatment;
Health Industry;
United States;
-
Supplement
| HBS Case Collection
|
2012
Amylin Pharmaceuticals (B)
Richard G. Hamermesh and Carin-Isabel Knoop
Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical company was hurt by long delays in bringing Bydureon, a once-a-week version of Byetta, to market, which allowed a competitor time to establish itself in the once-a-week market. Amylin also failed to develop a marketable anti-obesity drug after the purchase of the promising leptin molecule from Amgen, Inc. In 2012, Amylin was acquired by Bristol-Myers Squibb for $5.3 billion.
Keywords: Pharmaceuticals;
Bristol-Myers Squibb;
Health Care and Treatment;
Pharmaceutical Industry;
United States;
Citation:
Hamermesh, Richard G., and Carin-Isabel Knoop. "
Amylin Pharmaceuticals (B)." Harvard Business School Supplement 813-091, November 2012.
-
Case
| HBS Case Collection
|
2012
Westlake Lanes: How Can This Business Be Saved?
Richard G. Hamermesh and Alisa Zalosh
Shelby Givens, a new MBA, is the general manager of Westlake Lanes, a near-bankrupt bowling alley that her grandfather founded decades earlier. Givens has been given one year to turn a profit; if the goal is not met Westlake will close. During the first few days on the job, Givens learns that the business is in worse shape financially than she—or the board—thought. She also finds that Westlake's employees exhibit minimal productivity. Givens tackles these two issues, creatively uncovering ways to reduce costs while building morale. After nine months, the business has its first profitable month in over two years. Yet Givens is worried it is too little, too late and begins to sketch a bolder long-term strategy based on pursuing one of two alternative new markets. Students are invited to consider whether the board should accept her potentially transformative proposal, maintain existing operations, or liquidate to pay off pressing loan responsibilities. The case includes a quantitative assignment for students.
Keywords: United States;
operations management;
small and medium-sized enterprises;
turnarounds;
marketing strategy;
entrepreneurship;
strategy;
Leading Change;
Marketing Strategy;
Entrepreneurship;
Operations;
Transformation;
Growth and Development Strategy;
Entertainment and Recreation Industry;
United States;
-
Course Overview Note
|
2012
(Revised from original 2012 version)
Building Life Science Businesses Fall 2012: Course Outline and Syllabus
Richard G. Hamermesh and Richard G. Hamermesh
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses
Keywords: healthcare ventures;
entrepreneurial management;
entrepreneurship;
entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Health Industry;
Biotechnology Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe;
Citation:
Hamermesh, Richard G. "Building Life Science Businesses Fall 2012: Course Outline and Syllabus." Harvard Business School Course Overview Note 812-167, September 2012. (Revised from original June 2012 version.)
-
Supplement
| HBS Case Collection
|
2012
Meli Marine, Spreadsheet Supplement (Brief Case)
Richard G. Hamermesh and Sunru Yong
Keywords: Asia;
Singapore;
industry structure;
operations management;
capacity analysis;
supply chain management;
competitive strategy;
Logistics;
packaging cartons ＆containers;
-
Supplement
| HBS Case Collection
|
2012
Meli Marine, Instructor Supplement (Brief Case)
Richard G. Hamermesh and Sunru Yong
Keywords: Asia;
Singapore;
industry structure;
operations management;
capacity analysis;
supply chain management;
competitive strategy;
Logistics;
packaging cartons ＆containers;
-
Teaching Note
| HBS Case Collection
|
2012
Meli Marine (Brief Case)
Richard G. Hamermesh and Sunru Yong
Citation:
Hamermesh, Richard G., and Sunru Yong. "
Meli Marine (Brief Case)." Harvard Business School Teaching Note 124-427, April 2012.
-
Case
| HBS Case Collection
|
2012
Meli Marine
Richard G. Hamermesh and Sunru Yong
Citation:
Hamermesh, Richard G., and Sunru Yong. "
Meli Marine." Harvard Business School Brief Case 124-426, April 2012.
-
Supplement
| HBS Case Collection
|
2012
Gene Patents (B)
Richard Hamermesh and Phillip Andrews
Citation:
Hamermesh, Richard, and Phillip Andrews. "
Gene Patents (B)." Harvard Business School Supplement 812-130, March 2012.
-
Case
| HBS Case Collection
|
2012
(Revised from original 2011 version)
Gene Patents (A)
Richard Hamermesh, David Kiron and Phillip Andrews
In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues deal with the potential implications of Judge Sweet's decision for biotechnology entrepreneurs and investors.
Keywords: Courts and Trials;
Patents;
Genetics;
Judgments;
Science-Based Business;
Biotechnology Industry;
United States;
Citation:
Hamermesh, Richard, David Kiron, and Phillip Andrews. "
Gene Patents (A)." Harvard Business School Case 811-089, March 2012. (Revised from original June 2011 version.)
-
Background Note
| HBS Case Collection
|
2011
(Revised from original 2005 version)
Entrepreneurship and Venture Capital in Healthcare Fall Term 2011: Course Outline and Syllabus
Richard G. Hamermesh and Robert F. Higgins
Provides an overview of the second-year MBA elective course Entrepreneurship and Venture Capital in Healthcare.
Keywords: Entrepreneurship;
Venture Capital;
Health Care and Treatment;
-
Case
| HBS Case Collection
|
2012
(Revised from original 2011 version)
eHealthpoint: Healthcare for Rural India
Richard G. Hamermesh, Mona Sinha and Elizabeth Vrolyk
Healthpoint Services sought to address rural India's shortage of quality and affordable healthcare with a multi-service platform that comprised telemedical health clinics called eHealthpoints, clean drinking water, a diagnostic lab, and a pharmacy. Could they convince rural Indians to leapfrog from local healers to telemedicine? And could they convince Investors that their capital Intensive, bundled offering was a high-growth, self-sustaining venture? Healthpoint Services grappled with multiple challenges: changing mind-sets of patients and investors, generating traffic at their eHealthpoints, expanding their product portfolio, and growing within and outside India.
Keywords: Health Care and Treatment;
Health Industry;
India;
Citation:
Hamermesh, Richard G., Mona Sinha, and Elizabeth Vrolyk. "
eHealthpoint: Healthcare for Rural India." Harvard Business School Case 812-020, December 2012. (Revised from original October 2011 version.)
-
Case
| HBS Case Collection
|
2011
Gene Sequencing: Staking a Position in an Expanding Industry
Richard G. Hamermesh, Mara Aspinall and Phillip Andrews
Towards the end of 2010, companies in the gene sequencing industry were pushing aggressive R&D programs to develop technologies and products in the race to sequence the entire human genome at a cost of $1,000. It remained to be seen when the "$1,000 genome" would arrive, and despite all of the buzz surrounding the industry, it was still unclear to investors who the industry winners would be. This case focuses on the emergence of third-generation sequencing and the four segments in the industry: hardware, consumables, services, and interpretation. The case presents the history of the industry, the evolution of sequencing technology, and the business models of players in each segment.
-
Background Note
| HBS Case Collection
|
2011
(Revised from original 2011 version)
U.S. Universities and Technology Transfer
Richard G. Hamermesh, Josh Lerner and Phillip Andrews
Technology transfer from U.S. universities to industry has increased dramatically in the last 25 years. Reviews the history of technology transfer with particular emphasis on the Bayh-Dole Act of 1980. It then examines how universities responded to Bayh-Dole, the growth of technology transfer offices, and compares how three different universities (MIT, Stanford, and Harvard) approach technology transfer. Provides an overview of the technology transfer process and issues around current practices.
Keywords: Higher Education;
Technology;
Laws and Statutes;
Education Industry;
Technology Industry;
United States;
Citation:
Hamermesh, Richard G., Josh Lerner, and Phillip Andrews. "
U.S. Universities and Technology Transfer." Harvard Business School Background Note 812-016, September 2011. (Revised from original August 2011 version.)
-
Case
| HBS Case Collection
|
2011
(Revised from original 2010 version)
PrimedicProviding Primary Care in Mexico
Richard G. Hamermesh, Regina Garcia-Cuellar and Lauren Sarah Margulies
Primedic is a Mexican start-up that aims to deliver affordable primary and preventative healthcare to those at the base of the economic pyramid. The company is about to exhaust its first round of venture capital funding and the business model has yet to gain traction. How should the business model be changed and should the venture capitalists continue to fund the company?
Keywords: Business Model;
Business Startups;
Developing Countries and Economies;
Social Entrepreneurship;
Venture Capital;
Health Care and Treatment;
Social Enterprise;
Health Industry;
Mexico;
Citation:
Hamermesh, Richard G., Regina Garcia-Cuellar, and Lauren Sarah Margulies. "
PrimedicProviding Primary Care in Mexico." Harvard Business School Case 811-040, July 2011. (Revised from original October 2010 version.)
-
Teaching Note
| HBS Case Collection
|
2011
Whose Money Is It Anyway? (TN) (A), (B), and (C)
Richard G. Hamermesh, V.G. Narayanan and Rachel Gordon
Teaching Note for 810-008, 810-013, and 810-031.
Keywords: Health Industry;
-
Teaching Note
| HBS Case Collection
|
2011
Novasys Medical (TN)
Richard G. Hamermesh
Teaching Note for 810027.
Keywords: Product Development;
Health Care and Treatment;
Policy;
Medical Devices and Supplies Industry;
Citation:
Hamermesh, Richard G. "
Novasys Medical (TN)." Harvard Business School Teaching Note 811-084, June 2011.
-
Case
| HBS Case Collection
|
2011
(Revised from original 2011 version)
Horizon Blue Cross Blue Shield of New Jersey - Managing in the Shadow of Health Care Reform
Felix Oberholzer-Gee, Raffaella Sadun and Richard G. Hamermesh
Per the Patient Protection and Affordable Care Act (PPACA), which President Obama signed in 2010, states would be required to create state-wide health insurance marketplaces - the Health Benefit Exchanges (HBEs) - in which individuals and small employers could choose from a set of easy-to-compare, tightly regulated health plans. This case explores how Horizon Blue Cross Blue Shield of New Jersey would have to decide whether and how to compete in New Jersey's HBEs.
Keywords: Insurance;
Health Care and Treatment;
Governing Rules, Regulations, and Reforms;
Emerging Markets;
Risk and Uncertainty;
Health Industry;
Insurance Industry;
New Jersey;
-
Teaching Note
| HBS Case Collection
|
2011
PrimedicProviding Primary Care in Mexico (TN)
Richard G. Hamermesh
Teaching Note for 811040.
Keywords: Business Startups;
Health Care and Treatment;
Venture Capital;
Financing and Loans;
Business Model;
Medical Devices and Supplies Industry;
Mexico;
-
Case
| HBS Case Collection
|
2011
(Revised from original 2010 version)
Computerized Provider Order Entry at Emory Healthcare
Richard G. Hamermesh, F. Warren McFarlan, Mark Keil, Andrew Katz, Michael Morgan and David LaBorde
The Computerized Provider Order Entry at Emory Healthcare case presents one hospital system's efforts to implement computerized provider order entry (CPOE) across all of its hospitals and the challenges they faced in doing so. Issues such as standardization of care, how to handle medication reconciliation, and unexpected challenges (e.g., changes to the post-op ordering process, lack of a human gatekeeper to monitor order flow, increase in lab orders). Dr. Bill Bornstein, Chief Quality and Medical Officer of Emory Healthcare in Atlanta is responsible for the smooth implementation of CPOE at Emory Healthcare, which is a vital part of their $50 million electronic medical record initiative. By June 2009, CPOE had gone "live" at Emory University Orthopaedics and Spine Hospital, Emory University Hospital, and Wesley Woods Hospital in a staged rollout. While Dr. Bornstein felt good about how the implementation had gone thus far, as he looked ahead next month to July 13, 2009, the fast approaching go-live date for Emory University Hospital Midtown (EUHM), he was concerned about the challenges and possible perils that lay ahead. He considered what additional actions he should take to prepare for go-live at Midtown, and if Midtown was ready for CPOE at all. One thing was certain; this hospital was different. The Computerized Provider Order Entry at Emory Healthcare case presents one hospital system's efforts to grapple with the challenges of implementing CPOE and the reactions that result. Issues such as how to deal with a workforce that has mixed views about the value of implementing such systems, the pros and cons associated with standardization of care, as well as how to deal with unexpected changes to work processes are brought out in the case. The case also allows for discussion of how to plan a phased implementation with adequate time for organizational learning to occur between the time that various sites "go live."
Keywords: Health Care and Treatment;
Information Management;
Management Systems;
Standards;
Service Delivery;
Business Processes;
Organizational Change and Adaptation;
Projects;
Information Technology;
Software;
Health Industry;
-
Background Note
| HBS Case Collection
|
2011
(Revised from original 2001 version)
The Entrepreneurial Manager 2011 Winter Term: Course Overview
Richard G. Hamermesh
Course overview of The Entrepreneurial Manager.
Keywords: Entrepreneurship;
Management;
Business Education;
-
Background Note
| HBS Case Collection
|
2010
(Revised from original 2010 version)
Plavix: Drugs in the Age of Personalized Medicine
Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even death if they took PIavix. As a result, the FDA had added a black box warning—the agency's most severe—to Plavix's label in 2010. In addition, it had been discovered that the common combination of Plavix and Prilosec, an over-the-counter drug, could adversely affect patients. Finally, Plavix faced new competition from two new drugs with different mechanisms of action. This case reviews the recent history of Plavix in greater detail to encourage a discussion of the following questions: How might the current manufacturers of Plavix handle these emerging threats to their leading blockbuster? How might Plavix's potential competitors utilize Plavix's mixed history to their advantage? How should genotyping be integrated into the clinical care of patients in the light of emerging knowledge?
Keywords: Health Care and Treatment;
Product Positioning;
Business and Government Relations;
Genetics;
Competitive Strategy;
Pharmaceutical Industry;
-
Case
| HBS Case Collection
|
2010
(Revised from original 2007 version)
DermaCare: Zapping Zits Directly
Richard G. Hamermesh and Lauren Barley
DermaCare has developed an innovative new product for the treatment of acne that they hope to sell to consumers via direct-response television. The unconventional nature of the product and its distribution has led the company to seek angel financing. The Silicon Valley Band of Angels has agreed to finance the company and has submitted a proposed term sheet. Recently, however, a venture capital (VC) group has submitted a competing term sheet. The company must decide whether to accept financing from the Angels or the VC group.
Keywords: Decision Choices and Conditions;
Venture Capital;
Investment;
Innovation and Invention;
Product;
California;
Citation:
Hamermesh, Richard G., and Lauren Barley. "
DermaCare: Zapping Zits Directly." Harvard Business School Case 808-064, October 2010. (Revised from original September 2007 version.)
-
Teaching Note
| HBS Case Collection
|
2010
MINTing Innovation at NewYork-Presbyterian (TN)
Richard G. Hamermesh and David Kiron
Teaching Note for 810004.
Keywords: Commercialization;
Technological Innovation;
Health Industry;
-
Case
| HBS Case Collection
|
2010
(Revised from original 2009 version)
The Jenner Situation
Richard G. Hamermesh, Andy Whittemore and Eliot Sherman
Dr. Bill Lemont is the new chief medical officer of a large academic medical center. During his first week on the job he has become aware of the abusive behavior and temper outbursts of a prominent orthopedic surgeon. How Dr. Lemont handles the situation will be scrutinized inside and perhaps outside the hospital.
Keywords: Interpersonal Communication;
Employee Relationship Management;
Managerial Roles;
Behavior;
Conflict Management;
Health Industry;
Citation:
Hamermesh, Richard G., Andy Whittemore, and Eliot Sherman. "
The Jenner Situation." Harvard Business School Case 809-070, August 2010. (Revised from original May 2009 version.)
-
Case
| HBS Case Collection
|
2010
(Revised from original 2010 version)
Whose Money Is It Anyway? (A)
V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The Brigham and Women's Physician's Organization (BWPO) and its corporate parent disagree over who has jurisdiction over significant legacy funds. Are they controlled by the BWPO or do they belong to BWPO's corporate parent? The BWPO and its corporate parent must negotiate who has control of the funds which impacts how the funds may be used.
Keywords: Accounting;
Investment Funds;
Governance Controls;
Agreements and Arrangements;
Boundaries;
Health Industry;
Citation:
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "
Whose Money Is It Anyway? (A)." Harvard Business School Case 810-008, June 2010. (Revised from original March 2010 version.)
-
Teaching Note
| HBS Case Collection
|
2010
(Revised from original 2004 version)
Shurgard Self-Storage: Expansion to Europe and Shurgard Self-Storage: Expansion to Europe (Abridged) (TN)
Richard G. Hamermesh and Indra Reinbergs
Keywords: Europe;
-
Case
| HBS Case Collection
|
2010
(Revised from original 2008 version)
Proteus Biomedical: Making Pigs Fly
Richard G. Hamermesh, Lauren Barley and Ginger Graham
Proteus is a healthcare start-up that has developed technology to embed electronics for computing and sensing in existing medical devices and drugs. The technology could potentially change the basis of competition in the pharmaceutical industry. The company is currently considering a number of licensing and business development deals and must choose which one(s) to pursue.
Keywords: Business Startups;
Entrepreneurship;
Technological Innovation;
Rights;
Negotiation Deal;
Business Strategy;
Health Industry;
Medical Devices and Supplies Industry;
Pharmaceutical Industry;
Citation:
Hamermesh, Richard G., Lauren Barley, and Ginger Graham. "
Proteus Biomedical: Making Pigs Fly." Harvard Business School Case 809-051, April 2010. (Revised from original December 2008 version.)
-
Case
| HBS Case Collection
|
2010
(Revised from original 2009 version)
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several years prior. Moreover, Vectibix had also received Food and Drug Administration approval in 2006. During additional trials, Amgen has learned that the Vectibix is only effective with the 60% of the population that has a specific gene marker. Given this development, what should Amgen's strategy around Vectibix be both in Europe and the United States?
Keywords: Entrepreneurship;
Governing Rules, Regulations, and Reforms;
Health Testing and Trials;
Marketing Strategy;
Product Positioning;
Genetics;
Biotechnology Industry;
Europe;
United States;
-
Supplement
| HBS Case Collection
|
2010
Whose Money Is It Anyway? (B)
V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The case describes the various reactions of doctors and administrators to the solutions they developed.
Keywords: Corporate Governance;
Organizations;
Behavior;
Health Industry;
Citation:
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "
Whose Money Is It Anyway? (B)." Harvard Business School Supplement 810-013, March 2010.
-
Supplement
| HBS Case Collection
|
2010
Whose Money Is It Anyway? (C)
V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The case describes how the Brigham and Women's Physicians Organization and its corporate parent resolved the issue of how the disputed funds would be distributed and used.
Keywords: Corporate Governance;
Business Subsidiaries;
Organizational Design;
Conflict and Resolution;
Resource Allocation;
Health Industry;
Citation:
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "
Whose Money Is It Anyway? (C)." Harvard Business School Supplement 810-031, March 2010.
-
Case
| HBS Case Collection
|
2010
(Revised from original 2008 version)
Amylin Pharmaceuticals: Diabetes and Beyond
Richard G. Hamermesh and Rachel Gordon
Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation of taking the company's signature drug, Symlin, to market. However, unforeseen regulatory challenges have put the approval process in jeopardy. At the same time, the company has a second drug, Byetta, in its pipeline. Graham must decide how to manage the company's limited resources while also finalizing another deal that has huge future potential. Graham knows that Amylin's immediate success depends on its ability to commercialize its products, but its long-term success depends on replenishing its pipeline. Can the company do it all successfully?
Keywords: Governing Rules, Regulations, and Reforms;
Resource Allocation;
Negotiation Deal;
Product Development;
Research and Development;
Commercialization;
Pharmaceutical Industry;
-
Case
| HBS Case Collection
|
2010
Shurgard Self-Storage: Expansion to Europe (Abridged)
Richard G. Hamermesh
Shurgard, a U.S.-based firm that rents storage facilities to consumers and small businesses, is considering financing options for rapid expansion of its European operations. Five years after entering Europe, Shurgard Europe has opened 17 facilities in Belgium, France, and Sweden. Along the way, Shurgard has encountered skepticism from both European consumers and investors about the unfamiliar self-storage concept and internal debates on how much to adapt the U.S. business model to European lifestyles. Wall Street analysts also do not value the impact that the European expansion could have on Shurgard's U.S. performance as a publicly traded Real Estate Investment Trust (REIT). As an alternative, to finance this expansion, Shurgard received a proposed deal from a consortium of banks and other investors where they would provide private equity financing spaced over the next few years plus a line of credit. In return, the investors would receive a large share of Shurgard's equity and control of its board, which could force a public offering in less than two years. The decision focuses on whether Shurgard Europe should accept the conditions and valuation of the proposed deal or seek another deal at a later point in time. Students must assess whether the self-storage business model can deliver the growth rate in Europe that the company has promised his potential investors. Involves calculating some basic estimates of the company's value from financial exhibits (enterprise value using an EBITDA multiple). Main focus is to assess this as an entrepreneurial venture. Students do not need to be familiar with REITs.
Keywords: Business Model;
Business Growth and Maturation;
Multinational Firms and Management;
Logistics;
Corporate Entrepreneurship;
Trade;
Equity;
Corporate Finance;
United States;
Europe;
-
Teaching Note
| HBS Case Collection
|
2010
State of Emergency at Mercy Hospital and The Jenner Situation (TN)
Richard G. Hamermesh
Teaching Note for [809070] and [409048].
Keywords: Health;
Non-Governmental Organizations;
Health Industry;
-
Case
| HBS Case Collection
|
2012
(Revised from original 2009 version)
MINTing Innovation at NewYork-Presbyterian
Richard G. Hamermesh and David Kiron
Several top surgeons at NewYork-Presbyterian hospital (NYP) are receiving financial and administrative support to advance their surgical device inventions through the earliest stages of commercialization.
Keywords: Entrepreneurship;
Financing and Loans;
Investment;
Health Care and Treatment;
Innovation and Invention;
Intellectual Property;
Commercialization;
Health Industry;
Medical Devices and Supplies Industry;
New York (state, US);
-
Teaching Note
| HBS Case Collection
|
2010
(Revised from original 2008 version)
Calloway Laboratory: Pee for Profit (TN)
Richard G. Hamermesh
Teaching Note for [807-040].
Keywords: Profit;
-
Case
| HBS Case Collection
|
2009
The Explosion of Genetic Testing: Opportunities and Challenges
Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
This case study invites the reader to consider genetic testing in several different lights. First, can the business of genetic testing be considered a disruptive innovation to the current drug therapy model as defined by Harvard Business School Professor Clay Christensen? Secondly, which business models are likely to be the most successful? Finally, we encourage readers to explore possible future business implications and applications in the area of genetic testing while using a framework of disruptive innovation.
Keywords: Genetics;
Health Care and Treatment;
Health Testing and Trials;
Disruptive Innovation;
Business Model;
Biotechnology Industry;
Health Industry;
Citation:
Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "The Explosion of Genetic Testing: Opportunities and Challenges." Harvard Business School Case 810-067, November 2009.
-
Case
| HBS Case Collection
|
2012
(Revised from original 2009 version)
Novasys Medical
Richard G. Hamermesh and Lauren Barley
Novasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the product for reimbursement. The case deals with the company's struggle to obtain a reimbursement code.
Keywords: Entrepreneurship;
Governing Rules, Regulations, and Reforms;
Policy;
Health Care and Treatment;
Health Disorders;
Product Development;
Business and Government Relations;
Medical Devices and Supplies Industry;
United States;
Citation:
Hamermesh, Richard G., and Lauren Barley. "
Novasys Medical." Harvard Business School Case 810-027, August 2012. (Revised from original September 2009 version.)
-
Case
| HBS Case Collection
|
2009
(Revised from original 2007 version)
Syndexa and Technology Transfer at Harvard University
Richard G. Hamermesh and David Kiron
Gokhan Hotamisligil is a star researcher at Harvard School of Public Health who has made groundbreaking discoveries linking fat cells, inflammation, and diabetes. He now wants to form a company to commercialize these discoveries. At the same time, Isaac Kohlberg, the head of Harvard's Office of Technology Development (OTD), is eager to improve Harvard's record in commercializing science. Describes the negotiations between Hotamisligil, OTD, the new company, and the School of Public Health to establish appropriate licensing and sponsored research agreements.
Keywords: Business Startups;
Higher Education;
Entrepreneurship;
Innovation and Invention;
Intellectual Property;
Rights;
Agreements and Arrangements;
Science-Based Business;
Commercialization;
Biotechnology Industry;
Health Industry;
-
Teaching Note
| HBS Case Collection
|
2009
Amylin Pharmaceuticals: Diabetes and Beyond (TN)
Richard G. Hamermesh and Rachel Gordon
Teaching Note for [809011].
Keywords: Negotiation Deal;
Product Development;
Success;
Commercialization;
Governing Rules, Regulations, and Reforms;
Resource Allocation;
Pharmaceutical Industry;
-
Teaching Note
| HBS Case Collection
|
2009
Proteus Biomedical: Making Pigs Fly (TN)
Richard G. Hamermesh
Teaching Note for [809051].
Keywords: Business Startups;
Technology;
Competition;
Negotiation Deal;
Health Industry;
Pharmaceutical Industry;
-
Teaching Note
| HBS Case Collection
|
2009
Technology Transfer at U.S. Universities (TN)
Richard G. Hamermesh
Teaching Note for [807124].
Keywords: United States;
-
Teaching Note
| HBS Case Collection
|
2009
Syndexa and Technology Transfer at Harvard University (TN)
Richard G. Hamermesh
Teaching Note for [808073].
Keywords: Agreements and Arrangements;
Commercialization;
Science-Based Business;
Research;
Rights;
Pharmaceutical Industry;
-
Teaching Note
| HBS Case Collection
|
2009
(Revised from original 2006 version)
Molecular Insight Pharmaceuticals, Inc. (TN)
Richard G. Hamermesh and Erin Seefeld
Teaching Note to (805-067).
Keywords: Pharmaceutical Industry;
-
Teaching Note
| HBS Case Collection
|
2009
(Revised from original 2008 version)
Cynthia Fisher and the Rearing of ViaCell (TN)
Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld
Teaching Note for [806002].
Keywords: Management;
-
Case
| HBS Case Collection
|
2008
(Revised from original 2008 version)
Healthcare and Harvard Business School Alumni in 2008
Richard G. Hamermesh, Carin-Isabel Knoop and Cara Sterling
This case chronicles the role that Harvard Business School alumni play in the healthcare industry. Overall data on alumni is given, and the industry is broken into seven areas in which the careers of twenty-five alumni are highlighted.
Keywords: Business Education;
Executive Education;
Personal Development and Career;
Practice;
Health Industry;
-
Supplement
| HBS Case Collection
|
2008
ProfitLogic (CW)
Lynda M. Applegate, Richard G. Hamermesh and Michael J. Roberts
This interactive spreadsheet accompanies the ProfitLogic case (#802-110) to enable analysis of the cash flow implications of three business models that the company is considering. Students are able to change key assumptions and see the impact on cash flow.
Keywords: Cash Flow;
Business Model;
Citation:
Applegate, Lynda M., Richard G. Hamermesh, and Michael J. Roberts. "
ProfitLogic (CW)." Harvard Business School Spreadsheet Supplement 808-704, April 2008.
-
Teaching Note
| HBS Case Collection
|
2008
DermaCare: Zapping Zits Directly (TN)
Richard G. Hamermesh
Teaching Note for [808064].
Keywords: Product Development;
Innovation and Invention;
Health Care and Treatment;
Financing and Loans;
Venture Capital;
Advertising;
Distribution;
Health Industry;
-
Case
| HBS Case Collection
|
2007
(Revised from original 2005 version)
Fred Khosravi and AccessClosure
Richard G. Hamermesh and Elizabeth Kind
Fred Khosravi is a serial medical device entrepreneur. In his latest venture, he must decide whether to sell now or continue to develop his current product and whether to market it, sell the company, or IPO.
Keywords: Business Startups;
Decision Choices and Conditions;
Entrepreneurship;
Growth and Development Strategy;
Medical Devices and Supplies Industry;
Citation:
Hamermesh, Richard G., and Elizabeth Kind. "
Fred Khosravi and AccessClosure." Harvard Business School Case 806-044, August 2007. (Revised from original December 2005 version.)
-
Case
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Calloway Laboratory: Pee for Profit
Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business.
Keywords: For-Profit Firms;
Health Care and Treatment;
Health Testing and Trials;
Growth and Development Strategy;
Market Entry and Exit;
Health Industry;
Citation:
Hamermesh, Richard G., and David Kiron. "
Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, August 2007. (Revised from original October 2006 version.)
-
Case
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Corporate Venture Capital at Eli Lilly
Richard G. Hamermesh, Ron Laufer and David Lane
Reviews the role of corporate venture capital and its history at Eli Lilly. Also presents a challenging venture investment opportunity.
Keywords: Venture Capital;
Investment;
Pharmaceutical Industry;
Citation:
Hamermesh, Richard G., Ron Laufer, and David Lane. "
Corporate Venture Capital at Eli Lilly." Harvard Business School Case 806-092, July 2007. (Revised from original February 2006 version.)
-
Background Note
| HBS Case Collection
|
2007
(Revised from original 2007 version)
Technology Transfer at U.S. Universities
Richard G. Hamermesh, Josh Lerner and David Kiron
Technology transfer from U.S. universities to industry has increased dramatically in the last 25 years. Reviews the history of technology transfer with particular emphasis on the Bayh-Dole Act of 1980. It then examines how universities responded to Bayh-Dole, the growth of technology transfer offices, and compares how three different universities (MIT, Stanford, and Harvard) approach technology transfer. Provides an overview of the technology transfer process and issues around current practices.
Keywords: Higher Education;
Technology;
Laws and Statutes;
Education Industry;
Technology Industry;
United States;
Citation:
Hamermesh, Richard G., Josh Lerner, and David Kiron. "
Technology Transfer at U.S. Universities." Harvard Business School Background Note 807-124, June 2007. (Revised from original January 2007 version.)
-
Teaching Note
| HBS Case Collection
|
2007
Endo Pharmaceuticals Series (TN)
Richard G. Hamermesh, Brian DeLacey and Erin Seefeld
Keywords: Information;
-
Teaching Note
| HBS Case Collection
|
2007
DentalCorp (TN)
Richard G. Hamermesh and Erin Seefeld
Keywords: Health;
Health Industry;
Citation:
Hamermesh, Richard G., and Erin Seefeld. "
DentalCorp (TN)." Harvard Business School Teaching Note 807-163, May 2007.
-
Case
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Endo Pharmaceuticals (A): From LBO to...?
Richard G. Hamermesh and Brian DeLacey
Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company.
Keywords: Private Equity;
Initial Public Offering;
Leveraged Buyouts;
Mergers and Acquisitions;
Health Care and Treatment;
Pharmaceutical Industry;
United States;
-
Supplement
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Endo Pharmaceuticals (B): Merger Decision
Richard G. Hamermesh and Brian DeLacey
Keywords: Mergers and Acquisitions;
Pharmaceutical Industry;
-
Supplement
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Endo Pharmaceuticals (C): An "At Risk" Launch?
Richard G. Hamermesh and Brian DeLacey
Keywords: Product Launch;
Risk and Uncertainty;
Pharmaceutical Industry;
Citation:
Hamermesh, Richard G., and Brian DeLacey. Endo Pharmaceuticals (C): An "
At Risk" Launch? Harvard Business School Supplement 806-066, May 2007. (Revised from original January 2006 version.)
-
Supplement
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Endo Pharmaceuticals (D): Hatch-Waxman Change
Richard G. Hamermesh and Brian DeLacey
Keywords: Change;
Pharmaceutical Industry;
-
Supplement
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Endo Pharmaceuticals (E): Judge Stein Rules
Richard G. Hamermesh and Brian DeLacey
Keywords: Lawsuits and Litigation;
Pharmaceutical Industry;
-
Supplement
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Endo Pharmaceuticals (F): Appeals Court Ruling
Richard G. Hamermesh and Brian DeLacey
Keywords: Lawsuits and Litigation;
Pharmaceutical Industry;
-
Supplement
| HBS Case Collection
|
2007
(Revised from original 2006 version)
Corporate Venture Capital at Eli Lilly
Richard G. Hamermesh
Keywords: Management;
Business Ventures;
Pharmaceutical Industry;
-
Case
| HBS Case Collection
|
2007
(Revised from original 2005 version)
Cynthia Fisher and the Rearing of ViaCell
Robert F. Higgins, Richard G. Hamermesh and Ingrid Vargas
Describes the start up of Viacord, a Boston-based medical services firm founded by Cynthia Fisher (HBS MBA) in 1993. Told from Fisher's perspective, the entrepreneur details the conceptualization and launch of the business and the many obstacles and expenses faced in the company's first seven years. Fisher describes the venture capital negotiations and a merger with a biotech company that led to the creation of ViaCell in 2000. Fisher explains how her role changed from founder and CEO of Viacord to president and then board member of ViaCell, and carries the firm's story to the successful 2005 IPO.
Keywords: Managerial Roles;
Business Growth and Maturation;
Entrepreneurship;
Business Startups;
Service Industry;
Health Industry;
Boston;
-
Case
| HBS Case Collection
|
2007
(Revised from original 2004 version)
Cutlass Capital, L.P.
Richard G. Hamermesh and Brian DeLacey
David Hetz and Jon Osgood are forming a new venture capital fund in 2001 to invest in health care start-ups. Describes their fundraising activities at a time when venture capital investing has reached an all-time high. Although their background skills and experiences fall outside venture capital, they have identified a large investor and a number of smaller investors to back their small fund. They believe their fund's strategy uniquely addresses the strategic needs of large, corporate acquirers. At the same time, their approach addresses venture capital's reliance on public markets for liquidity events--which all but evaporated with the dot-com collapse of March 2000. Hetz and Osgood face challenging negotiations to close the fund. Raises the question of whether there is a need for a fund like this at the time of the case. Supports discussion of specialized versus generalized venture capital funds.
Keywords: Venture Capital;
Negotiation Process;
Entrepreneurship;
Investment Funds;
Health Care and Treatment;
Business Startups;
Health Industry;
United States;
Citation:
Hamermesh, Richard G., and Brian DeLacey. "
Cutlass Capital, L.P." Harvard Business School Case 805-075, March 2007. (Revised from original December 2004 version.)
-
Background Note
| HBS Case Collection
|
2007
(Revised from original 2007 version)
Note on the U.S. Food and Drug Administration
Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.
Keywords: Health;
Governance Compliance;
Policy;
Product Development;
Government and Politics;
Pharmaceutical Industry;
Medical Devices and Supplies Industry;
Biotechnology Industry;
Public Administration Industry;
United States;
-
Background Note
| HBS Case Collection
|
2007
Note on Biotech Business Development
Richard G. Hamermesh and Robert F. Higgins
Describes the business development process in biotechnology companies. Topics covered include: participants in the licensing process and their interests, the major steps in the licensing process, the terms that are part of most agreements, and the most contentious issues that arise in the implementation of licensing agreements.
-
Supplement
| HBS Case Collection
|
2006
Dental Corp--video
Richard G. Hamermesh
Keywords: Media;
Health Industry;
Citation:
Hamermesh, Richard G. "
Dental Corp--video." Harvard Business School Video Supplement 807-703, December 2006.
-
Teaching Note
| HBS Case Collection
|
2006
Corporate Venture Capital at Eli Lilly (TN)
Richard G. Hamermesh and Erin Seefeld
Keywords: Venture Capital;
Pharmaceutical Industry;
-
Case
| HBS Case Collection
|
2006
(Revised from original 2005 version)
DentalCorp
Richard G. Hamermesh and Ricardo Reisen de Pinho
DentalCorp is the fifth largest provider of dental insurance in Brazil and has tripled its sales in the past two years. Whether to expand to Chile or to continue expansion in Brazil is the major strategic choice facing the company at the end of 2004.
Keywords: International Finance;
Expansion;
Entrepreneurship;
Health Care and Treatment;
Global Strategy;
Insurance Industry;
Health Industry;
Brazil;
Chile;
Citation:
Hamermesh, Richard G., and Ricardo Reisen de Pinho. "
DentalCorp." Harvard Business School Case 806-023, September 2006. (Revised from original October 2005 version.)
-
Supplement
| HBS Case Collection
|
2006
Wu Xi Pharmatech
Richard G. Hamermesh
Keywords: Pharmaceutical Industry;
Citation:
Hamermesh, Richard G. "
Wu Xi Pharmatech." Harvard Business School Video Supplement 807-701, September 2006.
-
Supplement
| HBS Case Collection
|
2006
Cutlass Capital, L.P.: Discussion with David Hetz and Jon Osgood
Richard G. Hamermesh
Keywords: Capital;
Financial Services Industry;
-
Case
| HBS Case Collection
|
2006
(Revised from original 2005 version)
WuXi PharmaTech
Richard G. Hamermesh and Simin Zhou
WuXi Pharmatech has gone from zero to $21 million in sales in three years. The company must decide its growth strategy and how best to finance and organize for rapid growth.
Keywords: Growth Management;
Capital Markets;
Problems and Challenges;
Pharmaceutical Industry;
China;
Citation:
Hamermesh, Richard G., and Simin Zhou. "
WuXi PharmaTech." Harvard Business School Case 806-003, June 2006. (Revised from original September 2005 version.)
-
Teaching Note
| HBS Case Collection
|
2006
WuXi PharmaTech (TN)
Richard G. Hamermesh and Erin Seefeld
Keywords: Pharmaceutical Industry;
Citation:
Hamermesh, Richard G., and Erin Seefeld. "
WuXi PharmaTech (TN)." Harvard Business School Teaching Note 806-180, May 2006.
-
Background Note
| HBS Case Collection
|
2006
(Revised from original 2004 version)
Achieving Profitable Growth and Market Value
James L. Heskett and Richard G. Hamermesh
Provides an overview of how a new venture needs to change as it passes from the initial start-up to the growth phase. Explores how a venture's leadership, strategy, and execution need to evolve to deal with rapid growth.
Keywords: Growth Management;
Business Growth and Maturation;
Business Startups;
Change Management;
-
Teaching Note
| HBS Case Collection
|
2006
Cutlass Capital, L.P. (TN)
Richard G. Hamermesh and Erin Seefeld
Teaching Note to 805075.
Keywords: Financial Services Industry;
Citation:
Hamermesh, Richard G., and Erin Seefeld. "
Cutlass Capital, L.P. (TN)." Harvard Business School Teaching Note 806-155, March 2006.
-
Teaching Note
| HBS Case Collection
|
2006
Stan Lapidus: Profile of a Medical Entrepreneur (TN)
Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld
Teaching Note to (805-087).
Keywords: Personal Development and Career;
Entrepreneurship;
Business Startups;
Biotechnology Industry;
Pharmaceutical Industry;
-
Teaching Note
| HBS Case Collection
|
2006
Conor Medsystems (TN)
Robert F. Higgins, Richard G. Hamermesh and Erin Seefeld
Teaching Note to (804-180).
Keywords: Health Industry;
Citation:
Higgins, Robert F., Richard G. Hamermesh, and Erin Seefeld. "
Conor Medsystems (TN)." Harvard Business School Teaching Note 806-150, March 2006.
-
Teaching Note
| HBS Case Collection
|
2006
Fred Khosravi and AccessClosure (TN)
Richard G. Hamermesh and Erin Seefeld
Teaching Note to (806-044).
Keywords: Entrepreneurship;
Decision Choices and Conditions;
Mergers and Acquisitions;
Business Exit or Shutdown;
Initial Public Offering;
Medical Devices and Supplies Industry;
-
Case
| HBS Case Collection
|
2006
(Revised from original 2005 version)
Molecular Insight Pharmaceuticals, Inc.
Richard G. Hamermesh and Edwin W. Parkinson III
Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to raise $7 million in Series B financing. Should it continue its current strategy or change its approach? Includes color exhibits.
Keywords: Intellectual Property;
Health Care and Treatment;
Pharmaceutical Industry;
Health Industry;
Citation:
Hamermesh, Richard G., and Edwin W. Parkinson III. "
Molecular Insight Pharmaceuticals, Inc." Harvard Business School Case 805-067, March 2006. (Revised from original January 2005 version.)
-
Teaching Note
| HBS Case Collection
|
2006
John Moran and the Orthopedics Industry (TN)
Richard G. Hamermesh
Teaching Note to 805026.
Keywords: Health Industry;
-
Case
| HBS Case Collection
|
2006
(Revised from original 2003 version)
Threshold Sports
Richard G. Hamermesh and Todd H Thedinga
Describes the sales, marketing, and operating issues facing Threshold Sports, a small cycling event management company that produces the Pro Cycling Tour. Examines the issues facing the company as it approaches breakeven and attempts to grow the business substantially. The company must balance its growth objectives with a series of internal and external challenges. These include expanding the event to more cities, selling more sponsorships, expanding the TV coverage, and developing new revenue streams.
Keywords: Growth Management;
Bicycle Transportation;
Service Delivery;
Sports;
Bicycle Industry;
Service Industry;
Citation:
Hamermesh, Richard G., and Todd H Thedinga. "
Threshold Sports." Harvard Business School Case 803-134, January 2006. (Revised from original March 2003 version.)
-
Supplement
| HBS Case Collection
|
2005
Shurgard Self-Storage (video)
Richard G. Hamermesh
-
Supplement
| HBS Case Collection
|
2005
ProfitLogic: Scott Friend, CEO (DVD)
Richard G. Hamermesh and Michael J. Roberts
-
Supplement
| HBS Case Collection
|
2005
Vialog Corporation (DVD)
Richard G. Hamermesh
-
Supplement
| HBS Case Collection
|
2005
MAC Development Corporation (DVD)
Richard G. Hamermesh
-
Teaching Note
| HBS Case Collection
|
2005
ProfitLogic (TN)
Richard G. Hamermesh and Michael J. Roberts
Teaching Note to (9-802-110), (9-806-702), and (9-806-705).
Keywords: Information Technology Industry;
Service Industry;
Citation:
Hamermesh, Richard G., and Michael J. Roberts. "
ProfitLogic (TN)." Harvard Business School Teaching Note 806-057, September 2005.
-
Background Note
| HBS Case Collection
|
2005
(Revised from original 2005 version)
A Note on Managing the Growing Venture
Richard G. Hamermesh, James L. Heskett and Michael J. Roberts
Focuses on the strategic and organizational challenges that confront growing enterprises and the entrepreneurs who lead them. Provides an overview of how a new venture needs to change as it passes from the initial start-up to the growth phase. Explores how a venture's leadership, strategy, and execution need to evolve to deal with rapid growth. A rewritten version of an earlier note.
Keywords: Business Growth and Maturation;
Leading Change;
Citation:
Hamermesh, Richard G., James L. Heskett, and Michael J. Roberts. "
A Note on Managing the Growing Venture." Harvard Business School Background Note 805-092, August 2005. (Revised from original January 2005 version.)
-
Case
| HBS Case Collection
|
2005
(Revised from original 2004 version)
Shurgard Self-Storage: Expansion to Europe
Richard G. Hamermesh and Indra Reinbergs
Shurgard, a U.S.-based firm that rents storage facilities to consumers and small businesses, is considering financing options for rapid expansion of its European operations. Five years after entering Europe, Shurgard Europe has opened 17 facilities in Belgium, France, and Sweden. Along the way, Shurgard has encountered skepticism from both European consumers and investors about the unfamiliar self-storage concept and internal debates on how much to adapt the U.S. business model to European lifestyles. Wall Street analysts also do not value the impact that the European expansion could have on Shurgard's U.S. performance as a publicly traded Real Estate Investment Trust (REIT). As an alternative, to finance this expansion, Shurgard received a proposed deal from a consortium of banks and other investors where they would provide private equity financing spaced over the next few years plus a line of credit. In return, the investors would receive a large share of Shurgard's equity and control of its board, which could force a public offering in less than two years. The decision focuses on whether Shurgard Europe should accept the conditions and valuation of the proposed deal or seek another deal at a later point in time. Students must assess whether the self-storage business model can deliver the growth rate in Europe that the company has promised his potential investors. Involves calculating some basic estimates of the company's value from financial exhibits (enterprise value using a pEBITDA multiple). Main focus is to assess this as an entrepreneurial venture. Students do not need to be familiar with REITs.
Keywords: Private Equity;
Valuation;
Business Model;
Governing and Advisory Boards;
Entrepreneurship;
Cross-Cultural and Cross-Border Issues;
Service Industry;
Belgium;
France;
Sweden;
United States;
Europe;
-
Case
| HBS Case Collection
|
2005
(Revised from original 2004 version)
John Moran and the Orthopedics Industry
Richard G. Hamermesh
Reviews John Moran's 25-year career in the orthopedic industry and his current decision whether to start a hand and foot surgery company.
Keywords: Business Startups;
Decision Choices and Conditions;
Personal Development and Career;
Health Industry;
-
Case
| HBS Case Collection
|
2004
(Revised from original 2001 version)
Kingsley Management
Richard G. Hamermesh
Includes a brief overview of key challenges facing recent HBS graduates seeking funding for a business, followed by a 22-page excerpt from the Kingsley Management business plan. Describes Matthew Lieb and Chris Jones, two of the partners who developed the business plan for Kingsley Management, as they prepare to meet with potential investors. Lieb and Jones are particularly concerned about the investors' financial returns and the structure of the new business entity (i.e., C-corp. vs. LLC). Outlines several questions facing Lieb and his co-founders, which students are asked to resolve.
Keywords: Business Organization;
Corporate Entrepreneurship;
Business Plan;
Opportunities;
Investment Return;
Organizational Structure;
Citation:
Hamermesh, Richard G. "
Kingsley Management." Harvard Business School Case 801-474, November 2004. (Revised from original June 2001 version.)
-
Case
| HBS Case Collection
|
2004
(Revised from original 2003 version)
Managing Segway's Early Development
Richard G. Hamermesh and David Kiron
Describes the early development of the Segway Human Transporter and focuses on the organizational issues that arise between the parent company and the new company that is being spun out to produce and market the Segway. Key issues are the distribution of bonuses and stock options.
Keywords: Business Subsidiaries;
Business Startups;
Employee Stock Ownership Plan;
Resource Allocation;
Organizational Design;
Technology Adoption;
Citation:
Hamermesh, Richard G., and David Kiron. "
Managing Segway's Early Development." Harvard Business School Case 804-065, September 2004. (Revised from original December 2003 version.)
-
Teaching Note
| HBS Case Collection
|
2004
Managing Segway's Early Development (TN)
Richard G. Hamermesh
Teaching Note to (9-804-065).
-
Teaching Note
| HBS Case Collection
|
2004
Pre-Money / Post-Money Tutorial (Instructor Guide)
Richard G. Hamermesh and Michael J. Roberts
Teaching Note to (9-803-703).
Keywords: Entrepreneurship;
Valuation;
Finance;
Online Technology;
-
Case
| HBS Case Collection
|
2012
(Revised from original 1998 version)
Explo Leisure Products
Richard G. Hamermesh
Tim Trowac and Dave Rahall, two former investment bankers, skillfully execute the leveraged buyout of a golf ball recycling company after working intensely on their due diligence, writing a business and financial plan, and developing the investment memorandum. Six months later, they question the competency of their management team, which they had assembled from former Explo employees rather than conduct extensive searches. Now financial results are poor. Trowac and Rahall need to explain the poor performance and come up with an action plan for their investors.
Keywords: Selection and Staffing;
Leveraged Buyouts;
Business Plan;
Performance;
Management Teams;
Corporate Finance;
Business and Shareholder Relations;
Green Technology Industry;
Sports Industry;
Citation:
Hamermesh, Richard G. "
Explo Leisure Products." Harvard Business School Case 399-053, July 2012. (Revised from original November 1998 version.)
-
Teaching Note
| HBS Case Collection
|
2004
Resourcery, Ltd. (TN)
Richard G. Hamermesh
Teaching Note to (9-803-148).
Keywords: Nigeria;
Citation:
Hamermesh, Richard G. "
Resourcery, Ltd. (TN)." Harvard Business School Teaching Note 804-008, January 2004.
-
Case
| HBS Case Collection
|
2003
(Revised from original 2003 version)
Resourcery, Ltd.
Richard G. Hamermesh and Feyi A. Boroffice
Recounts the story of how a successful Nigerian entrepreneur has expanded his systems integration/networking business. He now faces the problem of raising growth capital in a developing country.
Keywords: Entrepreneurship;
Venture Capital;
Developing Countries and Economies;
Race Characteristics;
Expansion;
Growth Management;
Citation:
Hamermesh, Richard G., and Feyi A. Boroffice. "Resourcery, Ltd." Harvard Business School Case 803-148, November 2003. (Revised from original March 2003 version.)
-
Teaching Note
| HBS Case Collection
|
2003
(Revised from original 2003 version)
Threshold Sports (TN)
Richard G. Hamermesh and Todd H Thedinga
Teaching Note for (9-803-134).
Keywords: Sports Industry;
Citation:
Hamermesh, Richard G., and Todd H Thedinga. "
Threshold Sports (TN)." Harvard Business School Teaching Note 803-135, June 2003. (Revised from original March 2003 version.)
-
Case
| HBS Case Collection
|
2003
(Revised from original 2002 version)
MAC Development Corporation
Richard G. Hamermesh and Colleen McCaffrey
Deals with MAC Development's efforts to develop a 41-acre site near Chicago. Reviews two years of efforts and highlights the remaining issues of: 1) gaining town approval for development and tax reductions, 2) meeting the bank's debt covenants, including finding a buyer for the first lot, and 3) agreeing on a final purchase price with the seller. Includes color exhibits.
Keywords: Risk Management;
Taxation;
Financial Instruments;
Borrowing and Debt;
Asset Pricing;
Construction Industry;
Chicago;
Citation:
Hamermesh, Richard G., and Colleen McCaffrey. "
MAC Development Corporation." Harvard Business School Case 802-140, June 2003. (Revised from original March 2002 version.)
-
Case
| HBS Case Collection
|
2003
(Revised from original 2002 version)
ProfitLogic
Richard G. Hamermesh, Michael J. Roberts and Taslim Pirmohamed
Describes an "application software" company that has been through several evolutions--from consulting firm to applications service provider (ASP). The firm has received significant venture funding to pursue the ASP model but this has not worked, at least at the time the case ends. The company faces a choice: continuing with its current ASP business model, increasing its burn rate to convert to a licensed software model, or decreasing its burn rate to offer a more custom version of the ASP product.
Keywords: History;
Business Model;
Venture Capital;
Cash Flow;
Decision Choices and Conditions;
Balanced Scorecard;
Information Technology Industry;
Service Industry;
Citation:
Hamermesh, Richard G., Michael J. Roberts, and Taslim Pirmohamed. "
ProfitLogic." Harvard Business School Case 802-110, May 2003. (Revised from original January 2002 version.)
-
Supplement
| HBS Case Collection
|
2003
Jim Sharpe: Extrusion Technology, Inc.
Richard G. Hamermesh and Paul W. Marshall
Jim Sharpe discusses his early career at General Electric to his decision to purchase and run a small company. The discussion includes a detailed acquisition financing proposal, which resulted in Sharpe being able to raise virtually all of the financing from some combination of the seller and the bank.
Keywords: Personal Development and Career;
Entrepreneurship;
Business Startups;
Mergers and Acquisitions;
Financing and Loans;
-
Teaching Note
| HBS Case Collection
|
2003
(Revised from original 2001 version)
Kingsley Management TN
Richard G. Hamermesh and Michelle Lutz
Teaching Note for (801-474).
Citation:
Hamermesh, Richard G., and Michelle Lutz. "
Kingsley Management TN." Harvard Business School Teaching Note 801-484, April 2003. (Revised from original June 2001 version.)
-
Tutorial
|
2003
Pre-Money / Post-Money Tutorial
Richard G. Hamermesh, Nitin Nohria, Michael J. Roberts, Arleen Ahearn-Cavanaugh and Sal Darji
An online, interactive tutorial that addresses issues surrounding entrepreneurial valuations. Topics include: the difference between an implied and a "bottom-up" valuation; the difference between pre-money and post-money valuations; the calculation of pre-money and post-money valuations; and the creation and interpretation of a capitalization table.
Keywords: Money;
Citation:
Hamermesh, Richard G., Nitin Nohria, Michael J. Roberts, Arleen Ahearn-Cavanaugh, and Sal Darji.
Pre-Money / Post-Money Tutorial. Harvard Business School Tutorial 803-703, February 2003.
-
Teaching Note
| HBS Case Collection
|
2002
MAC Development Corporation (TN)
Richard G. Hamermesh
Teaching Note for (2-802-140), (9-806-703), and (9-806-706).
Keywords: Construction Industry;
Chicago;
-
Case
| HBS Case Collection
|
2002
(Revised from original 2002 version)
Vialog Corporation
Richard G. Hamermesh and Michele Lutz
Traces the origin of Vialog Corp.--from its founding in 1996 through a roll-up of several independent teleconferencing companies in 1997 and its initial public offering (1999) and eventually to a potential merger or acquisition in June 2000. The company has grown rapidly and has the option of merging with an Internet company or another strategic partner, or selling to a European strategic partner.
Keywords: History;
Business Exit or Shutdown;
Internet;
Corporate Entrepreneurship;
Partners and Partnerships;
Initial Public Offering;
Business Growth and Maturation;
Mergers and Acquisitions;
Business Processes;
Information Technology Industry;
Europe;
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Vialog Corporation." Harvard Business School Case 802-008, July 2002. (Revised from original January 2002 version.)
-
Teaching Note
| HBS Case Collection
|
2002
(Revised from original 2002 version)
Vialog Corporation (TN)
Richard G. Hamermesh and Michele Lutz
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Vialog Corporation (TN)." Harvard Business School Teaching Note 802-053, July 2002. (Revised from original January 2002 version.)
-
Background Note
| HBS Case Collection
|
2002
Note on Business Model Analysis for the Entrepreneur
Richard G. Hamermesh, Paul W. Marshall and Taslim Pirmohamed
Describes the primary elements and defining characteristics of a company's business model from the perspective of an entrepreneur. Introduces several analytic techniques and provides illustrative examples of business models to support the analytic framework presented.
Keywords: Business Model;
Entrepreneurship;
Framework;
Mathematical Methods;
Opportunities;
Perspective;
-
Teaching Note
| HBS Case Collection
|
2001
(Revised from original 2001 version)
Return Logic, Inc. (A) and (B) TN
Richard G. Hamermesh and Michele Lutz
Teaching Note for (9-801-167) and (9-801-168).
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Return Logic, Inc. (A) and (B) TN." Harvard Business School Teaching Note 801-366, May 2001. (Revised from original January 2001 version.)
-
Case
| HBS Case Collection
|
2001
(Revised from original 2001 version)
Balance, Inc. (A)
Richard G. Hamermesh and Michele Lutz
Focuses on an entrepreneur who founded a successful health-food store and seeks to expand his retail concept. Illustrates the challenges he faces as he recruits his top management team.
Keywords: Distribution Channels;
Executive Compensation;
Agreements and Arrangements;
Outcome or Result;
Recruitment;
Management Teams;
Selection and Staffing;
Food and Beverage Industry;
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Balance, Inc. (A)." Harvard Business School Case 801-169, May 2001. (Revised from original February 2001 version.)
-
Teaching Note
| HBS Case Collection
|
2001
(Revised from original 2001 version)
Balance, Inc. (A) and (B) TN
Richard G. Hamermesh and Michele Lutz
Teaching Note for (9-801-169) and (9-801-170).
Keywords: Entrepreneurship;
Food and Beverage Industry;
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Balance, Inc. (A) and (B) TN." Harvard Business School Teaching Note 801-372, May 2001. (Revised from original February 2001 version.)
-
Case
| HBS Case Collection
|
2001
(Revised from original 2001 version)
Return Logic, Inc. (A)
Richard G. Hamermesh and Michele Lutz
Follows three graduating HBS students as they build a business-to-business Internet venture and highlights the challenges they confront in structuring financing terms with venture capitalists. Requires students to carefully read a six-page term sheet to identify which provisions should and should not be accepted.
Keywords: Venture Capital;
Investment Funds;
Private Equity;
Internet;
Negotiation Deal;
Entrepreneurship;
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Return Logic, Inc. (A)." Harvard Business School Case 801-167, May 2001. (Revised from original January 2001 version.)
-
Case
| HBS Case Collection
|
2001
(Revised from original 2001 version)
Return Logic, Inc. (B)
Richard G. Hamermesh and Michele Lutz
Highlights how multiple rounds of financing work in practice and illustrates how terms agreed to in early-stage financing deals have an impact in later financing rounds. Also illustrates ethical issues that entrepreneurs confront as they build "dot-com" ventures.
Keywords: Venture Capital;
Investment Funds;
Private Equity;
Internet;
Negotiation Deal;
Entrepreneurship;
Ethics;
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Return Logic, Inc. (B)." Harvard Business School Case 801-168, May 2001. (Revised from original January 2001 version.)
-
Case
| HBS Case Collection
|
2001
(Revised from original 2001 version)
Lawyers & Leases
Richard G. Hamermesh and Michele Lutz
Profiles Rajath Chaundry, an aspiring entrepreneur, as he attempts to secure office space for his growing team, select a lawyer, and continue to build his fledgling enterprise, eLearning.com. Designed to be used in an entrepreneurial management or small business course to illustrate the importance of early negotiations in the life of a business venture.
Keywords: Entrepreneurship;
Business or Company Management;
Business Ventures;
Corporate Entrepreneurship;
Intellectual Property;
Management Succession;
Leasing;
Negotiation;
Education Industry;
Legal Services Industry;
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Lawyers & Leases." Harvard Business School Case 801-166, April 2001. (Revised from original January 2001 version.)
-
Case
| HBS Case Collection
|
2001
(Revised from original 2001 version)
Balance, Inc. (B)
Richard G. Hamermesh and Michele Lutz
Supplements the (A) case.
Keywords: Entrepreneurship;
Food and Beverage Industry;
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Balance, Inc. (B)." Harvard Business School Case 801-170, April 2001. (Revised from original February 2001 version.)
-
Teaching Note
| HBS Case Collection
|
2001
(Revised from original 2001 version)
Lawyers & Leases TN
Richard G. Hamermesh and Michele Lutz
Teaching Note for (9-801-166).
Keywords: Contracts;
Negotiation;
Entrepreneurship;
Internet;
Education;
Education Industry;
Citation:
Hamermesh, Richard G., and Michele Lutz. "
Lawyers & Leases TN." Harvard Business School Teaching Note 801-353, April 2001. (Revised from original January 2001 version.)
-
Supplement
| HBS Case Collection
|
1999
STT Aerospace: Interview with Charles Damon, Chairman and CEO, February 8, 1999
Richard G. Hamermesh and Jeremy Dann
-
Supplement
| HBS Case Collection
|
1999
(Revised from original 1999 version)
STT Aerospace, Supplement
Richard G. Hamermesh and Jeremy Dann
Supplements the case.
Keywords: Aerospace Industry;
Citation:
Hamermesh, Richard G., and Jeremy Dann. "
STT Aerospace, Supplement." Harvard Business School Supplement 399-078, October 1999. (Revised from original January 1999 version.)
-
Case
| HBS Case Collection
|
1999
(Revised from original 1999 version)
Bloomberg L.P.
Clayton M. Christensen, Richard G. Hamermesh and Jeremy Dann
Michael Bloomberg founded his company to provide customers quick access to financial market data and analytical tools for understanding that data. As Bloomberg L.P. grew quickly,entered the ranks of "large, established companies," it grappled with a whole new range of human resources, organizational, and corporate culture issues.
Keywords: Human Resources;
Management Analysis, Tools, and Techniques;
Organizational Culture;
Organizational Structure;
Problems and Challenges;
Citation:
Christensen, Clayton M., Richard G. Hamermesh, and Jeremy Dann. "
Bloomberg L.P." Harvard Business School Case 399-081, June 1999. (Revised from original February 1999 version.)
-
Teaching Note
| HBS Case Collection
|
1999
STT Aerospace and Supplement TN
Richard G. Hamermesh
Teaching Note for (9-399-056) and (9-399-078).
Keywords: Aerospace Industry;
-
Case
| HBS Case Collection
|
1999
(Revised from original 1998 version)
STT Aerospace
Richard G. Hamermesh and Jeremy Dann
Experienced entrepreneur Charles Damon conducted a "roll-up" from 1987-1994 within the commercial airliner interior products industry. Damon's company, STT Aerospace, took advantage of an industry-wide recession in the early 1990s by buying when asset prices were low. The strategy's success was borne out by the company's growth and success in the marketplace. However, the company faced its own set of problems as the industry downturn continued. Critical decisions to be made at the end of the case include: 1) Whether or not STT should continue its acquisition strategy in the face of declining profits; 2) If the company should reset the strike price of options packages, a big part of employee compensation; and 3) If they should invest in a breakthrough high-tech product.
Keywords: Retention;
Business Strategy;
Selection and Staffing;
Entrepreneurship;
Financial Crisis;
Growth and Development Strategy;
Compensation and Benefits;
Employee Stock Ownership Plan;
Acquisition;
Product Development;
Aerospace Industry;
Citation:
Hamermesh, Richard G., and Jeremy Dann. "
STT Aerospace." Harvard Business School Case 399-056, June 1999. (Revised from original December 1998 version.)
-
Supplement
| HBS Case Collection
|
1999
(Revised from original version)
Orthoteks USA (B3)
Joseph L. Badaracco Jr. and Richard G. Hamermesh
Supplements the (A) case.
Keywords: Health Industry;
United States;
Citation:
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "
Orthoteks USA (B3)." Harvard Business School Supplement 384-060, May 1999. (Revised from original September 1983 version.)
-
Teaching Note
| HBS Case Collection
|
1999
Explo Leisure Products TN
Richard G. Hamermesh
Teaching Note for (9-399-053).
-
Case
| HBS Case Collection
|
1999
(Revised from original 1998 version)
Specialty Medical Chemicals
Richard G. Hamermesh and Lucinda Doran
A new general manager is supposed to rekindle growth. Seven months later, he questions the abilities of his direct reports. An organizational psychologist is brought in to assess his people. The general manager now has to decide who to keep and how to structure his direct report team.
Keywords: Decisions;
Employees;
Leadership Development;
Management Teams;
Organizational Structure;
Cognition and Thinking;
Citation:
Hamermesh, Richard G., and Lucinda Doran. "
Specialty Medical Chemicals." Harvard Business School Case 399-094, May 1999. (Revised from original December 1998 version.)
-
Teaching Note
| HBS Case Collection
|
1998
Mitek Corporation TN
Richard G. Hamermesh
Citation:
Hamermesh, Richard G. "Mitek Corporation TN." Harvard Business School Teaching Note 398-181, June 1998.
-
Teaching Note
| HBS Case Collection
|
1998
PC&D, Inc. TN
Richard G. Hamermesh
Teaching Note for (9-380-072).
Citation:
Hamermesh, Richard G. "
PC&D, Inc. TN." Harvard Business School Teaching Note 398-183, June 1998.
-
Teaching Note
| HBS Case Collection
|
1998
Orthoteks USA Series TN
Joseph L. Badaracco Jr. and Richard G. Hamermesh
Teaching Note for (9-384-057), (9-384-058), (9-384-059), (9-384-060), (9-384-061), and (9-384-062).
Keywords: Health Industry;
United States;
Switzerland;
Citation:
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "
Orthoteks USA Series TN." Harvard Business School Teaching Note 398-126, June 1998.
-
Teaching Note
| HBS Case Collection
|
1995
Cleveland Twist Drill (A) and (B) TN
Richard G. Hamermesh and Joseph L. Bower
Teaching Note for (9-384-083) and (9-384-163).
-
Case
| HBS Case Collection
|
1993
(Revised from original version)
General Electric: Strategic Position--1981
Francis Aguilar and Richard G. Hamermesh
Describes the introduction and evolution of General Electric's strategic planning system from the 1960s to Jack Welch's tenure. Allows discussion of the interplay of problems and circumstances to the evolution of the strategic planning system, and how Welch might use or alter the system to meet the challenge of growth.
Keywords: History;
Strategic Planning;
Growth Management;
Corporate Entrepreneurship;
Management Systems;
Policy;
Management Teams;
-
Case
| HBS Case Collection
|
1993
(Revised from original version)
General Electric Co.--1984
Francis Aguilar and Richard G. Hamermesh
Describes the first four years of Jack Welch's tenure as CEO of the General Electric Co. Deals with the ways Welch has tried to change GE's strategy and planning activities and his attempts to make the company more entrepreneurial.
Keywords: Management Teams;
Management Style;
Change Management;
Strategic Planning;
Corporate Strategy;
Corporate Entrepreneurship;
Organizational Change and Adaptation;
Citation:
Aguilar, Francis, and Richard G. Hamermesh. "
General Electric Co.--1984." Harvard Business School Case 385-315, March 1993. (Revised from original May 1985 version.)
-
Case
| HBS Case Collection
|
1991
(Revised from original version)
Orthoteks USA (A)
Joseph L. Badaracco Jr. and Richard G. Hamermesh
A series on implementing strategy as the head of the U.S. subsidiary of a successful Swiss medical products firm. Traces the actions of the CEO over a four year period and highlights his negotiations with the Swiss parent and the way functional components of the strategy were developed and integrated. Describes Hans Wyss' first eight months as CEO of Orthoteks USA.
Keywords: Business Subsidiaries;
Trade;
Health Care and Treatment;
Leadership Style;
Agreements and Arrangements;
Strategy;
Health Industry;
Switzerland;
United States;
Citation:
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "
Orthoteks USA (A)." Harvard Business School Case 384-057, July 1991. (Revised from original September 1983 version.)
-
Case
| HBS Case Collection
|
1989
(Revised from original 1984 version)
Cleveland Twist Drill (B)
Richard G. Hamermesh
Describes events at Cleveland Twist Drill between April 1982 and February 1983. Jim Bartlett's approach to the union and the implementation of the "move strategy" are described. Students are asked to evaluate these actions and to develop plans for dealing with current problems and with recent overtures from the union president.
Keywords: History;
Management Style;
Leadership Style;
Standards;
Power and Influence;
Citation:
Hamermesh, Richard G. "
Cleveland Twist Drill (B)." Harvard Business School Case 384-163, May 1989. (Revised from original May 1984 version.)
-
Case
| HBS Case Collection
|
1988
(Revised from original version)
Cleveland Twist Drill (A)
Richard G. Hamermesh
Deals with the problems of implementing strategy in a declining industry and the negotiation of strategy with external constituencies, particularly labor unions. Traces Jim Bartlett's first nine months as president and asks for a plan of action.
Keywords: Decision Choices and Conditions;
Management Style;
Negotiation Tactics;
Labor and Management Relations;
Corporate Strategy;
Citation:
Hamermesh, Richard G. "
Cleveland Twist Drill (A)." Harvard Business School Case 384-083, December 1988. (Revised from original September 1983 version.)
-
Background Note
| HBS Case Collection
|
1988
(Revised from original version)
Note on Implementing Strategy
Richard G. Hamermesh
Presents a framework for thinking about problems of implementing strategy. Defines the tasks of implementation and the range of implementation situations, then develops four approaches to implementation and reviews a range of implementation skills. Intended for use in Business Policy II in conjunction with case studies.
Keywords: Strategy;
Citation:
Hamermesh, Richard G. "
Note on Implementing Strategy." Harvard Business School Background Note 383-015, October 1988. (Revised from original September 1982 version.)
-
Case
| HBS Case Collection
|
1988
Crown Cork & Seal Co., Inc. (Condensed)
Richard G. Hamermesh and Richard S. Rosenbloom
A condensed version of Crown Cork & Seal Co., Inc. The principal changes are the elimination of details about the early history of the company and condensation of the final section, Outlook for the Future.
-
Case
| HBS Case Collection
|
1987
(Revised from original version)
Crown Cork & Seal Co., Inc.
Richard G. Hamermesh
Describes the technical, economic, and competitive trends in the metal container industry. The strategy of Crown Cork and Seal is then described in relation to these trends. Focuses on two immediate threats to Crown's strategy: the future of aerosol cans, given the ozone problem; and the impact of the banning of nonreturnable containers.
Keywords: Law;
SWOT Analysis;
Organizational Culture;
Problems and Challenges;
Safety;
Corporate Strategy;
Manufacturing Industry;
Citation:
Hamermesh, Richard G. "
Crown Cork & Seal Co., Inc." Harvard Business School Case 378-024, April 1987. (Revised from original August 1977 version.)
-
Supplement
| HBS Case Collection
|
1986
(Revised from original version)
Orthoteks USA (C)
Joseph L. Badaracco Jr. and Richard G. Hamermesh
Supplements the (A) case.
Keywords: Health Care and Treatment;
Health Industry;
United States;
Citation:
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "
Orthoteks USA (C)." Harvard Business School Supplement 384-061, July 1986. (Revised from original September 1983 version.)
-
Case
| HBS Case Collection
|
1986
(Revised from original version)
International Harvester (B1)
Richard G. Hamermesh and Evelyn T. Christiansen
Keywords: Manufacturing Industry;
Agriculture and Agribusiness Industry;
Citation:
Hamermesh, Richard G., and Evelyn T. Christiansen. "
International Harvester (B1)." Harvard Business School Case 381-053, June 1986. (Revised from original October 1980 version.)
-
Teaching Note
| HBS Case Collection
|
1986
International Harvester (A), (B1), (B2), (B3), (B4), (C), and (D), Teaching Note
Richard G. Hamermesh and Evelyn T. Christiansen
Citation:
Hamermesh, Richard G., and Evelyn T. Christiansen. "International Harvester (A), (B1), (B2), (B3), (B4), (C), and (D), Teaching Note." Harvard Business School Teaching Note 386-125, June 1986.
-
Supplement
| HBS Case Collection
|
1986
Lyric Dinner Theatre: Deborah Denenberg, General Manager, Video
Richard G. Hamermesh
Presents Deborah Denenberg, general manager, answering questions about her successful turnaround of an ailing dinner theatre.
Keywords: Managerial Roles;
Restructuring;
Business Ventures;
Arts;
Entertainment and Recreation Industry;
Food and Beverage Industry;
-
Case
| HBS Case Collection
|
1986
(Revised from original version)
PC&D, Inc.
Evelyn T. Christiansen and Richard G. Hamermesh
Covers history of PC&D from 1960 to 1975 as it grows from a single business firm to a diversified firm. Emphasizes the use of subsidiaries for product development and fast growth. Other issues include problems of a new CEO in keeping control of fast growing divisions.
Keywords: Business Subsidiaries;
Business History;
Leadership;
Growth Management;
Product Development;
Problems and Challenges;
Diversification;
Citation:
Christiansen, Evelyn T., and Richard G. Hamermesh. "
PC&D, Inc." Harvard Business School Case 380-072, March 1986. (Revised from original October 1979 version.)
-
Supplement
| HBS Case Collection
|
1986
General Electric--1984: John F. Welch, Jr., Video
Richard G. Hamermesh and Francis Aguilar
-
Teaching Note
| HBS Case Collection
|
1985
(Revised from original version)
Dexter Corp., Teaching Note
Richard G. Hamermesh
Citation:
Hamermesh, Richard G. "Dexter Corp., Teaching Note." Harvard Business School Teaching Note 379-172, December 1985. (Revised from original April 1979 version.)
-
Teaching Note
| HBS Case Collection
|
1985
(Revised from original version)
Fuqua Industries (A), (B), and (C), Teaching Note
Malcolm S. Salter and Richard G. Hamermesh
Citation:
Salter, Malcolm S., and Richard G. Hamermesh. "Fuqua Industries (A), (B), and (C), Teaching Note." Harvard Business School Teaching Note 375-280, October 1985. (Revised from original February 1975 version.)
-
Teaching Note
| HBS Case Collection
|
1985
(Revised from original version)
Crown Cork & Seal Co., Inc., Teaching Note
Richard G. Hamermesh
Teaching Note for (9-378-024).
Keywords: Manufacturing Industry;
-
Teaching Note
| HBS Case Collection
|
1985
(Revised from original version)
Federated Department Stores, Teaching Note
Joseph L. Bower and Richard G. Hamermesh
Keywords: Retail Industry;
Citation:
Bower, Joseph L., and Richard G. Hamermesh. "Federated Department Stores, Teaching Note." Harvard Business School Teaching Note 375-304, October 1985. (Revised from original March 1975 version.)
-
Supplement
| HBS Case Collection
|
1985
(Revised from original version)
Orthoteks USA (B1)
Joseph L. Badaracco Jr. and Richard G. Hamermesh
Supplements the (A) case.
Keywords: Health Industry;
United States;
Citation:
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "
Orthoteks USA (B1)." Harvard Business School Supplement 384-058, September 1985. (Revised from original September 1983 version.)
-
Supplement
| HBS Case Collection
|
1985
(Revised from original version)
Orthoteks USA (B2)
Joseph L. Badaracco Jr. and Richard G. Hamermesh
Supplements the (A) case.
Keywords: Health Industry;
United States;
Citation:
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "
Orthoteks USA (B2)." Harvard Business School Supplement 384-059, September 1985. (Revised from original September 1983 version.)
-
Case
| HBS Case Collection
|
1985
(Revised from original version)
Federated Department Stores
Joseph L. Bower and Richard G. Hamermesh
Keywords: Retail Industry;
Citation:
Bower, Joseph L., and Richard G. Hamermesh. "
Federated Department Stores." Harvard Business School Case 375-147, June 1985. (Revised from original November 1974 version.)
-
Case
| HBS Case Collection
|
1985
(Revised from original version)
General Electric: Business Development
Francis Aguilar and Richard G. Hamermesh
Keywords: Business Growth and Maturation;
Diversification;
-
Supplement
| HBS Case Collection
|
1985
Cleveland Twist Drill: Jim Bartlett, Video
Richard G. Hamermesh and Daniel F. Muzyka
Presents a question and answer session with Jim Bartlett, president of Cleveland Twist Drill. Edited into three parts. Bartlett provides additional insights into the case situation and also describes subsequent events at the company.
Keywords: Management Teams;
Corporate Strategy;
Policy;
Construction Industry;
Consumer Products Industry;
-
Case
| HBS Case Collection
|
1985
(Revised from original version)
International Harvester (A)
Richard G. Hamermesh and Evelyn T. Christiansen
Keywords: Agriculture and Agribusiness Industry;
Manufacturing Industry;
Citation:
Hamermesh, Richard G., and Evelyn T. Christiansen. "
International Harvester (A)." Harvard Business School Case 381-052, January 1985. (Revised from original October 1980 version.)
-
Case
| HBS Case Collection
|
1985
(Revised from original version)
International Harvester (D)
Richard G. Hamermesh
Keywords: Agriculture and Agribusiness Industry;
Manufacturing Industry;
Citation:
Hamermesh, Richard G. "
International Harvester (D)." Harvard Business School Case 383-035, January 1985. (Revised from original November 1982 version.)
-
Case
| HBS Case Collection
|
1983
(Revised from original version)
Dexter Corp.
Richard G. Hamermesh
Citation:
Hamermesh, Richard G. "
Dexter Corp." Harvard Business School Case 379-112, September 1983. (Revised from original February 1979 version.)
-
Supplement
| HBS Case Collection
|
1983
Orthoteks USA (D)
Joseph L. Badaracco Jr. and Richard G. Hamermesh
Supplements the (A) case.
Keywords: Health Industry;
United States;
Switzerland;
Citation:
Badaracco, Joseph L., Jr., and Richard G. Hamermesh. "
Orthoteks USA (D)." Harvard Business School Supplement 384-062, September 1983.
-
Supplement
| HBS Case Collection
|
1983
General Electric: John F. Welch, Jr., Chairman of the Board, Video Transcript
Francis Aguilar and Richard G. Hamermesh
Transcript for Video (9-882-524).
Keywords: Industrial Products Industry;
-
Case
| HBS Case Collection
|
1983
(Revised from original version)
Fuqua Industries (A)
Malcolm S. Salter and Richard G. Hamermesh
Citation:
Salter, Malcolm S., and Richard G. Hamermesh. "
Fuqua Industries (A)." Harvard Business School Case 375-189, May 1983. (Revised from original December 1974 version.)
-
Supplement
| HBS Case Collection
|
1983
(Revised from original version)
BiC Pen Corp. (A), Supplement
Richard G. Hamermesh
Supplements the (A) case.
Keywords: Consumer Products Industry;
Citation:
Hamermesh, Richard G. "
BiC Pen Corp. (A), Supplement." Harvard Business School Supplement 378-086, May 1983. (Revised from original September 1977 version.)
-
Supplement
| HBS Case Collection
|
1983
International Harvester: Comments on Tenure as CEO, Video
Richard G. Hamermesh
-
Supplement
| HBS Case Collection
|
1982
General Electric: Strategic Planning, Corporate Goals, and the Job of the Chief Executive, Video
Richard G. Hamermesh and Francis Aguilar
Introduces Reginald Jones, former CEO of General Electric. Presents a question and answer session with Jones and Advanced Management Program participants.
Keywords: Managerial Roles;
Corporate Strategy;
Strategic Planning;
Goals and Objectives;
-
Supplement
| HBS Case Collection
|
1982
General Electric: John F. Welch, Jr., Chairman of the Board, Video
Francis Aguilar and Richard G. Hamermesh
Welch discusses a variety of topics.
Keywords: Management Teams;
Governing and Advisory Boards;
Spoken Communication;
Industrial Products Industry;
-
Supplement
| HBS Case Collection
|
1981
International Harvester: The First Two Years, Video
Richard G. Hamermesh
Keywords: History;
Agribusiness;
United States;
-
Supplement
| HBS Case Collection
|
1981
International Harvester: Future Prospects and the Strike, Video
Richard G. Hamermesh
-
Case
| HBS Case Collection
|
1981
(Revised from original version)
International Harvester (B2)
Richard G. Hamermesh and Evelyn T. Christiansen
Keywords: Manufacturing Industry;
Agriculture and Agribusiness Industry;
Citation:
Hamermesh, Richard G., and Evelyn T. Christiansen. "
International Harvester (B2)." Harvard Business School Case 381-054, April 1981. (Revised from original November 1980 version.)
-
Case
| HBS Case Collection
|
1981
(Revised from original version)
International Harvester (B4)
Richard G. Hamermesh and Evelyn T. Christiansen
Keywords: Manufacturing Industry;
Agriculture and Agribusiness Industry;
Citation:
Hamermesh, Richard G., and Evelyn T. Christiansen. "
International Harvester (B4)." Harvard Business School Case 381-056, March 1981. (Revised from original November 1980 version.)
-
Case
| HBS Case Collection
|
1981
(Revised from original version)
International Harvester (C)
Richard G. Hamermesh and Evelyn T. Christiansen
Keywords: Agriculture and Agribusiness Industry;
Manufacturing Industry;
Citation:
Hamermesh, Richard G., and Evelyn T. Christiansen. "
International Harvester (C)." Harvard Business School Case 381-057, March 1981. (Revised from original November 1980 version.)
-
Case
| HBS Case Collection
|
1980
International Harvester (B3)
Richard G. Hamermesh and Evelyn T. Christiansen
Keywords: Agriculture and Agribusiness Industry;
Manufacturing Industry;
-
Case
| HBS Case Collection
|
1980
(Revised from original version)
Mitek Corp.
Richard G. Hamermesh and Evelyn T. Christiansen
Citation:
Hamermesh, Richard G., and Evelyn T. Christiansen. "
Mitek Corp." Harvard Business School Case 379-110, October 1980. (Revised from original February 1979 version.)
-
Case
| HBS Case Collection
|
1980
(Revised from original version)
Management Succession and Board Membership
Richard G. Hamermesh
Keywords: Management Succession;
Governing and Advisory Boards;
-
Teaching Note
| HBS Case Collection
|
1980
Management Succession and Board Membership, Teaching Note
Richard G. Hamermesh
Keywords: Management Succession;
Governing and Advisory Boards;
Citation:
Hamermesh, Richard G. "Management Succession and Board Membership, Teaching Note." Harvard Business School Teaching Note 380-187, April 1980.
-
Supplement
| HBS Case Collection
|
1979
Mitek Corp., Supplement
Richard G. Hamermesh and Evelyn T. Christiansen
Citation:
Hamermesh, Richard G., and Evelyn T. Christiansen. "
Mitek Corp., Supplement." Harvard Business School Supplement 379-111, February 1979.
-
Teaching Note
| HBS Case Collection
|
1978
Bishopric, Inc., Teaching Note
Richard G. Hamermesh
Citation:
Hamermesh, Richard G. "Bishopric, Inc., Teaching Note." Harvard Business School Teaching Note 378-279, June 1978.
-
Case
| HBS Case Collection
|
1977
Bishopric, Inc.
Richard G. Hamermesh
Citation:
Hamermesh, Richard G. "
Bishopric, Inc." Harvard Business School Case 378-025, October 1977.
-
Case
| HBS Case Collection
|
1975
(Revised from original version)
Fuqua Industries (C)
Malcolm S. Salter and Richard G. Hamermesh
Citation:
Salter, Malcolm S., and Richard G. Hamermesh. "
Fuqua Industries (C)." Harvard Business School Case 375-191, April 1975. (Revised from original December 1974 version.)
-
Supplement
| HBS Case Collection
|
1974
Fuqua Industries (B)
Malcolm S. Salter and Richard G. Hamermesh
Citation:
Salter, Malcolm S., and Richard G. Hamermesh. "
Fuqua Industries (B)." Harvard Business School Supplement 375-190, December 1974.